Actinium Pharmaceuticals, Inc.
ATNMNYSEAMERICANHealthcareBiotechnology
As of Oct 26, 2026 close
- Market cap
- $43.97M
- P/E (TTM)
- 3.89
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.74$1.74
- Volume (live)
- -
- Avg. volume (3M)
- 193.75K
Actinium Pharmaceuticals (ATNM) Stock Price & Financial Analysis
Actinium Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.38 - $1.52 |
|---|---|
| 52-Week High | $1.74 |
| 52-Week Low | $0.74 |
| Open | $1.52 |
| Volume (last close) | 205.86K |
| Average Volume (3M) | 193.75K |
| Revenue (TTM) | 35.09M |
|---|---|
| Net Income (TTM) | 11.31M |
| Free Cash Flow (TTM) | -23.25M |
| EPS (TTM) | $0.36 |
| Profit Margin | 32.23% |
| Operating Margin | 27.23% |
| Return on Equity (ROE) | 37.32% |
| Debt to Equity | 0.04 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 43.97M |
|---|---|
| Shares Outstanding | 31.41M |
| P/E Ratio (TTM) | 3.89 |
| Price to Sales (P/S) | 1.25 |
| Price to Book (P/B) | 1.45 |
| EV/EBITDA | 1.33 |
| 50-Day MA | $1.12 |
|---|---|
| 200-Day MA | $1.12 |
| 1-Year Change | +11.89% |
Source: Market prices and company fundamentals. Data as of Oct 26, 2026. Data sources and methodology
Actinium Pharmaceuticals at a Glance
As of the Oct 26, 2026 close, Actinium Pharmaceuticals (ATNM) has a market capitalization of $43.97M. The stock trades at 3.9× trailing earnings and 1.3× sales. Over the trailing twelve months it earned $11.31M on revenue of $35.09M (a 32.2% profit margin) and burned $23.25M of free cash flow. Revenue grew 11.1% year over year.
As of its latest reported balance sheet, it holds $36.47M in cash and securities against $1.34M of debt, a net cash position of $35.13M.
Actinium Pharmaceuticals does not currently pay a dividend.
The share price is up 11.9% over the past year. At $1.40 (the Oct 26, 2026 close) it sits within its 52-week range of $0.74 to $1.74, above its 200-day moving average of $1.12.
Frequently Asked Questions About Actinium Pharmaceuticals
What is the current stock price for ATNM?
As of the Oct 26, 2026 close, ATNM stock trades at $1.40. The 52-week range is $0.74–$1.74, with a day range of $1.38–$1.52.
What is the P/E ratio for ATNM?
As of the Oct 26, 2026 close, Actinium Pharmaceuticals's trailing twelve-month (TTM) P/E ratio is 3.9, meaning investors pay $3.9 for every $1 of annual earnings. Actinium Pharmaceuticals operates in the Healthcare sector.
Does ATNM pay dividends?
Actinium Pharmaceuticals does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for ATNM?
Analyst ratings and recommendations for ATNM are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ATNM?
As of the Oct 26, 2026 close, Actinium Pharmaceuticals's market capitalization is $44.0M, classifying it as a micro-cap company. Actinium Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.